This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Everfront Biotech Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations of Hong-Meng Chuang in Pulmonary Fibrosis Treatment
Introduction
Hong-Meng Chuang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of pulmonary fibrosis. His innovative approach has the potential to improve the quality of life for many patients suffering from this condition.
Latest Patents
Hong-Meng Chuang holds a patent for a method aimed at delaying the onset of pulmonary fibrosis or treating the disease. The patent, titled "Method for delaying the onset of pulmonary fibrosis or treating pulmonary fibrosis," involves administering an effective amount of an active ingredient selected from a specific group of compounds. This innovative method showcases his commitment to advancing medical treatments.
Career Highlights
Chuang is associated with Everfront Biotech Inc., where he continues to work on groundbreaking research and development in biotechnology. His dedication to innovation in the medical field is evident through his patent and ongoing projects.
Collaborations
Hong-Meng Chuang collaborates with esteemed colleagues, including Hong-Lin Su and Shinn-Zong Lin. Their combined expertise enhances the research efforts at Everfront Biotech Inc. and contributes to the advancement of medical science.
Conclusion
Hong-Meng Chuang's work in developing methods for treating pulmonary fibrosis exemplifies the impact of innovation in healthcare. His contributions are paving the way for new treatments that could benefit countless individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile